164 related articles for article (PubMed ID: 15078216)
1. Partial agonists for A(3) adenosine receptors.
Gao ZG; Jacobson KA
Curr Top Med Chem; 2004; 4(8):855-62. PubMed ID: 15078216
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.
Gao ZG; Jeong LS; Moon HR; Kim HO; Choi WJ; Shin DH; Elhalem E; Comin MJ; Melman N; Mamedova L; Gross AS; Rodriguez JB; Jacobson KA
Biochem Pharmacol; 2004 Mar; 67(5):893-901. PubMed ID: 15104242
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA
J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926
[TBL] [Abstract][Full Text] [Related]
4. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA
J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421
[TBL] [Abstract][Full Text] [Related]
5. N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.
Gao ZG; Blaustein JB; Gross AS; Melman N; Jacobson KA
Biochem Pharmacol; 2003 May; 65(10):1675-84. PubMed ID: 12754103
[TBL] [Abstract][Full Text] [Related]
6. Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety.
Gao ZG; Joshi BV; Klutz AM; Kim SK; Lee HW; Kim HO; Jeong LS; Jacobson KA
Bioorg Med Chem Lett; 2006 Feb; 16(3):596-601. PubMed ID: 16289820
[TBL] [Abstract][Full Text] [Related]
7. "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
Perreira M; Jiang JK; Klutz AM; Gao ZG; Shainberg A; Lu C; Thomas CJ; Jacobson KA
J Med Chem; 2005 Jul; 48(15):4910-8. PubMed ID: 16033270
[TBL] [Abstract][Full Text] [Related]
8. Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.
Melman A; Gao ZG; Kumar D; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
Bioorg Med Chem Lett; 2008 May; 18(9):2813-9. PubMed ID: 18424135
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880
[TBL] [Abstract][Full Text] [Related]
10. 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.
Gao ZG; Mamedova LK; Chen P; Jacobson KA
Biochem Pharmacol; 2004 Nov; 68(10):1985-93. PubMed ID: 15476669
[TBL] [Abstract][Full Text] [Related]
11. Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.
Kim SK; Gao ZG; Jeong LS; Jacobson KA
J Mol Graph Model; 2006 Dec; 25(4):562-77. PubMed ID: 16793299
[TBL] [Abstract][Full Text] [Related]
12. Purine derivatives as ligands for A3 adenosine receptors.
Joshi BV; Jacobson KA
Curr Top Med Chem; 2005; 5(13):1275-95. PubMed ID: 16305531
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
Cappellacci L; Franchetti P; Pasqualini M; Petrelli R; Vita P; Lavecchia A; Novellino E; Costa B; Martini C; Klotz KN; Grifantini M
J Med Chem; 2005 Mar; 48(5):1550-62. PubMed ID: 15743197
[TBL] [Abstract][Full Text] [Related]
14. Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.
Tosh DK; Phan K; Deflorian F; Wei Q; Yoo LS; Gao ZG; Jacobson KA
Bioconjug Chem; 2012 Feb; 23(2):232-47. PubMed ID: 22175234
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor.
Jeong LS; Lee HW; Jacobson KA; Kim HO; Shin DH; Lee JA; Gao ZG; Lu C; Duong HT; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
J Med Chem; 2006 Jan; 49(1):273-81. PubMed ID: 16392812
[TBL] [Abstract][Full Text] [Related]
16. Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position.
Ohno M; Gao ZG; Van Rompaey P; Tchilibon S; Kim SK; Harris BA; Gross AS; Duong HT; Van Calenbergh S; Jacobson KA
Bioorg Med Chem; 2004 Jun; 12(11):2995-3007. PubMed ID: 15142558
[TBL] [Abstract][Full Text] [Related]
17. 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.
Cosyn L; Palaniappan KK; Kim SK; Duong HT; Gao ZG; Jacobson KA; Van Calenbergh S
J Med Chem; 2006 Dec; 49(25):7373-83. PubMed ID: 17149867
[TBL] [Abstract][Full Text] [Related]
18. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.
Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN
Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786
[TBL] [Abstract][Full Text] [Related]
19. Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives.
Storme J; Tosh DK; Gao ZG; Jacobson KA; Stove CP
Biochem Pharmacol; 2018 Dec; 158():103-113. PubMed ID: 30292756
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of adenosine derivatives as A
Bednarska-Szczepaniak K; Mieczkowski A; Kierozalska A; Pavlović Saftić D; Głąbała K; Przygodzki T; Stańczyk L; Karolczak K; Watała C; Rao H; Gao ZG; Jacobson KA; Leśnikowski ZJ
Eur J Med Chem; 2021 Nov; 223():113607. PubMed ID: 34171656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
